Suppr超能文献

实验性鼻病毒感染作为慢性阻塞性肺疾病加重的人类模型。

Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.

机构信息

Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College London, Norfolk Place, London W2 1PG, UK.

出版信息

Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42. doi: 10.1164/rccm.201006-0833OC. Epub 2010 Oct 1.

Abstract

RATIONALE

Respiratory virus infections are associated with chronic obstructive pulmonary disease (COPD) exacerbations, but a causative relationship has not been proven. Studies of naturally occurring exacerbations are difficult and the mechanisms linking virus infection to exacerbations are poorly understood. We hypothesized that experimental rhinovirus infection in subjects with COPD would reproduce the features of naturally occurring COPD exacerbations and is a valid model of COPD exacerbations.

OBJECTIVES

To evaluate experimental rhinovirus infection as a model of COPD exacerbation and to investigate the mechanisms of virus-induced exacerbations.

METHODS

We used experimental rhinovirus infection in 13 subjects with COPD and 13 nonobstructed control subjects to investigate clinical, physiologic, pathologic, and antiviral responses and relationships between virus load and these outcomes.

MEASUREMENTS AND MAIN RESULTS

Clinical data; inflammatory mediators in blood, sputum, and bronchoalveolar lavage; and viral load in nasal lavage, sputum, and bronchoalveolar lavage were measured at baseline and after infection with rhinovirus 16. After rhinovirus infection subjects with COPD developed lower respiratory symptoms, airflow obstruction, and systemic and airway inflammation that were greater and more prolonged compared with the control group. Neutrophil markers in sputum related to clinical outcomes and virus load correlated with inflammatory markers. Virus load was higher and IFN production by bronchoalveolar lavage cells was impaired in the subjects with COPD.

CONCLUSIONS

We have developed a new model of COPD exacerbation that strongly supports a causal relationship between rhinovirus infection and COPD exacerbations. Impaired IFN production and neutrophilic inflammation may be important mechanisms in virus-induced COPD exacerbations.

摘要

背景

呼吸道病毒感染与慢性阻塞性肺疾病(COPD)加重有关,但尚未证明两者存在因果关系。自然发生的加重事件研究较为困难,病毒感染与加重之间的联系机制也知之甚少。我们假设在 COPD 患者中进行的实验性鼻病毒感染将重现自然发生的 COPD 加重的特征,并且是 COPD 加重的有效模型。

目的

评估实验性鼻病毒感染作为 COPD 加重模型,并研究病毒引起加重的机制。

方法

我们使用 13 名 COPD 患者和 13 名非阻塞性对照者的实验性鼻病毒感染来研究临床、生理、病理和抗病毒反应以及病毒载量与这些结果之间的关系。

测量和主要结果

在感染鼻病毒 16 前后测量了临床数据;血液、痰和支气管肺泡灌洗液中的炎症介质;以及鼻冲洗、痰和支气管肺泡灌洗液中的病毒载量。在鼻病毒感染后,COPD 患者出现下呼吸道症状、气流阻塞以及全身和气道炎症,与对照组相比,这些症状更为严重且持续时间更长。痰中的中性粒细胞标志物与临床结果和病毒载量相关,与炎症标志物相关。COPD 患者的病毒载量更高,支气管肺泡灌洗液细胞产生 IFN 的能力受损。

结论

我们已经开发出一种新的 COPD 加重模型,该模型强烈支持鼻病毒感染与 COPD 加重之间存在因果关系。IFN 产生受损和中性粒细胞炎症可能是病毒引起的 COPD 加重的重要机制。

相似文献

1
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42. doi: 10.1164/rccm.201006-0833OC. Epub 2010 Oct 1.
2
Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
Chest. 2016 Jan;149(1):62-73. doi: 10.1378/chest.14-2637. Epub 2016 Jan 6.
3
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24. doi: 10.1164/rccm.201205-0806OC. Epub 2012 Sep 28.
4
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
J Allergy Clin Immunol. 2020 Oct;146(4):840-850.e7. doi: 10.1016/j.jaci.2020.03.021. Epub 2020 Apr 10.
5
Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
J Allergy Clin Immunol. 2018 Sep;142(3):815-823.e6. doi: 10.1016/j.jaci.2017.10.017. Epub 2018 Jan 5.
6
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease.
Respir Med. 2014 Jan;108(1):78-85. doi: 10.1016/j.rmed.2013.09.010. Epub 2013 Sep 22.
7
Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
Chest. 2010 Apr;137(4):812-22. doi: 10.1378/chest.09-1541. Epub 2009 Oct 16.
8
Antiviral immunity is impaired in COPD patients with frequent exacerbations.
Am J Physiol Lung Cell Mol Physiol. 2019 Dec 1;317(6):L893-L903. doi: 10.1152/ajplung.00253.2019. Epub 2019 Sep 12.
9
Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease.
Am J Physiol Lung Cell Mol Physiol. 2025 Jan 1;328(1):L120-L133. doi: 10.1152/ajplung.00118.2024. Epub 2024 Nov 19.

引用本文的文献

1
Viruses in bronchiectasis.
ERJ Open Res. 2025 Sep 1;11(5). doi: 10.1183/23120541.01131-2024. eCollection 2025 Sep.
3
Advances in the Treatment of Enterovirus-D68 and Rhinovirus Respiratory Infections.
Infect Dis Rep. 2025 Jun 1;17(3):61. doi: 10.3390/idr17030061.
5
Hidden in plain sight: the impact of human rhinovirus infection in adults.
Respir Res. 2025 Mar 28;26(1):120. doi: 10.1186/s12931-025-03178-w.
7
Select Airway Specialized Pro-Resolving Mediators Are Associated with Recovery from Non-Viral COPD Exacerbations.
Am J Respir Crit Care Med. 2025 Mar 5;211(5):803-13. doi: 10.1164/rccm.202407-1325OC.
8
Inherent immunity and adaptive immunity: Mechanism and role in AECOPD.
Innate Immun. 2025 Jan-Dec;31:17534259251322612. doi: 10.1177/17534259251322612.
9
Assessment of Rhinovirus Infection in a Mouse Model of COPD.
Methods Mol Biol. 2025;2903:165-171. doi: 10.1007/978-1-0716-4410-2_13.
10
In Vivo Model to Assess the Nasal Infection by Minor Group Rhinovirus.
Methods Mol Biol. 2025;2903:141-152. doi: 10.1007/978-1-0716-4410-2_11.

本文引用的文献

1
Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study.
Respir Res. 2010 Jun 15;11(1):77. doi: 10.1186/1465-9921-11-77.
2
Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2010 Aug 1;182(3):332-40. doi: 10.1164/rccm.200911-1673OC. Epub 2010 Apr 15.
3
Globe still in grip of addiction.
Nature. 2010 Feb 25;463(7284):1020-1. doi: 10.1038/4631020a.
4
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.
Lancet. 2009 Aug 29;374(9691):685-94. doi: 10.1016/S0140-6736(09)61255-1.
5
6
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2009 Jan 21(1):CD001288. doi: 10.1002/14651858.CD001288.pub3.
7
Temporal clustering of exacerbations in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2009 Mar 1;179(5):369-74. doi: 10.1164/rccm.200807-1067OC. Epub 2008 Dec 12.
8
Inflammatory response in acute viral exacerbations of COPD.
Infection. 2008 Oct;36(5):427-33. doi: 10.1007/s15010-008-7327-5. Epub 2008 Sep 15.
9
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production.
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13562-7. doi: 10.1073/pnas.0804181105. Epub 2008 Sep 3.
10
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7. doi: 10.1164/rccm.200708-1234OC. Epub 2007 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验